SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/08/22 Darling Ingredients Inc. 8-K:1,9 9/06/22 11:1.7M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 28K 2: EX-10.1 Material Contract HTML 1.31M 6: R1 Document and Entity Information HTML 45K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- d354137d8k_htm XML 13K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- dar-20220906_lab XML 53K 5: EX-101.PRE XBRL Presentations -- dar-20220906_pre XML 34K 3: EX-101.SCH XBRL Schema -- dar-20220906 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 11± 18K 11: ZIP XBRL Zipped Folder -- 0001193125-22-240463-xbrl Zip 312K
8-K |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) i September 6, 2022
i DARLING INGREDIENTS INC.
(Exact Name of Registrant as Specified in Charter)
i Delaware | i 001-13323 | i 36-2495346 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
i 5601 N. MACARTHUR BLVD., i IRVING, TEXAS | i 75038 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: i (972) i 717-0300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
i Common stock $0.01 par value per share | i DAR | i New York Stock Exchange (“NYSE”) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
i ☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. | Entry into a Definitive Material Agreement. |
Effective September 6, 2022, Darling Ingredients Inc., a Delaware corporation (the “Company”), and certain of its subsidiaries entered into an amendment (the “Ninth Amendment”) to that certain Second Amended and Restated Credit Agreement, dated as of January 6, 2014 (as amended, the “Credit Agreement”), among the Company, as parent borrower, certain of the Company’s subsidiaries as borrowers and/or guarantors thereunder, JPMorgan Chase Bank, N.A., as administrative agent, the lending institutions party thereto and the other agents party thereto. Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Credit Agreement.
Among other things, the Ninth Amendment (a) adds (i) a new delayed draw incremental term facility (the “Term A-3 Facility”) and new Incremental Term Loans pursuant thereto, in an aggregate principal amount of up to $300,000,000, and (ii) a new delayed draw incremental term facility (the “Term A-4 Facility”) and new Incremental Term Loans pursuant thereto, in an aggregate principal amount of up to $500,000,000 which, in each case, will be made available to the Company and have maturity dates co-terminous with the Company’s previously existing delayed draw Term A-1 Facility and Term A-2 Facility, and (b) updates and modifies certain other terms and provisions of the Credit Agreement to reflect the addition of the Term A-3 Facility and Term A-4 Facility to the Credit Agreement.
These new delayed draw facilities provide the Company with additional liquidity for strategic growth opportunities that may arise in the future.
The summary set forth above is not intended to be complete and is qualified in its entirety by reference to the full text of the Ninth Amendment attached hereto as Exhibit 10.1.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
10.1 | Ninth Amendment to Second Amended and Restated Credit Agreement, dated as of September 6, 2022, by and among Darling Ingredients Inc., as the parent borrower, the other subsidiary borrowers party thereto, the subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders party thereto. | |
104 | Cover Page Interactive Data File (embedded within Inline XBRL document) |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DARLING INGREDIENTS INC. | ||||||
Date: September 8, 2022 | By: | /s/ John F. Sterling | ||||
John F. Sterling | ||||||
Executive Vice President, | ||||||
General Counsel |
3
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 9/8/22 | |||
For Period end: | 9/6/22 | |||
1/6/14 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 Darling Ingredients Inc. 10-K 12/30/23 136:21M 2/27/23 Darling Ingredients Inc. 10-K 12/31/22 131:23M 11/08/22 Darling Ingredients Inc. 10-Q 10/01/22 101:14M |